Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors

Pharmaceutical Research

Volumn 13, Issue 12, 1996, Pages 1892-1895

  Buolamwini, John K ^a   Raghavan, Krishnamchari ^b   Fesen, Mark R ^b   Pommier, Yves ^b   Kohn, Kurt W ^b   Weinstein, John N ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Electrotopological state index; Flavones; HIV 1 integrase inhibitors; Partial least squares; Quantitative structure activity relationships

Indexed keywords

ENZYME INHIBITOR; FLAVONE DERIVATIVE; INTEGRASE;

ARTICLE; CHEMICAL MODIFICATION; DRUG DESIGN; HUMAN IMMUNODEFICIENCY VIRUS 1; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

FLAVONOIDS; HIV INTEGRASE INHIBITORS; HIV-1; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030471086     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016005813432     Document Type: Article

References (17)

1. M. I. Johnston, and D. F. Hoth. Science 267:1286-1293 (1993).
2. P. S. Anderson, G. L. Kenyon and G. R. Marshall (eds.), Perspectives in Drug Discovery and Design 1: Supplement to Computer-Aided Molecular Design, ESCOM Science Publishers, 1993.
3. H. E. Varmus and P. O. Brown. In D. E. Berg and M. M. Howe (eds.), Mobile DNA, American Society for Microbiology, Washington DC, 1989, pp. 53-108.
4. R. L. LaFemina, C. L. Schneider, H. L. Robbins, P. L. Callahan, K. Legrow, E. Roth, W. A. Schleif, and E. A. Emini. J. Virol. 66:7414-7419 (1992).
5. F. D. Bushman, and R. Craigie. Proc. Natl. Acad. Sci. USA 88:1339-1343 (1991).
6. A. Engelman, K. Mizuuchi, and R. Craigie. Cell 67:1211-122 (1991).
7. M. R. Fesen, K. W. Kohn, F. Leuteurtre, and Y. Pommier. Proc. Natl. Acad. Sci. U.S.A. 90:2399-2403 (1993).
8. M. R. Fesen, Y. Pommier, F. Leuteurtre, S. Hiroguchi, J. Yung, and K. W. Kohn. Biochem. Pharmacol. 48:595-608 (1994).
9. L. B. Kier, and L. H. Hall. Pharm. Res. 7:801-807 (1990).
10. L. B. Kier, and L. H. Hall. Adv. Drug Res. 22: 1-138 (1992).
11. H. Wold. In Systems under Indirect Observation, Part II, Joreskog, K. G. and Wold, H., Eds., Horth Holland, Amsterdam, 1982, pp. 1-54.
12. Kleinbaum, D. G.; Kupper, L. L. and Muller, K. E. Applied Regression Analysis and Other Multivariate Methods, PWS-KENT Publishing Company, Boston, 1988.
13. K. Raghavan, J. K. Buolamwini, M. R. Fesen, Y. Pommier, K. W. Kohn, and J. N. Weinstein. J. Med. Chem. 38:890-897 (1995).
14. Theory Manual of SYBYL Molecular Modeling Software, Version 6.2, Tripos Associates, Inc., St. Louis, MO, 1995.
15. F. Dyda, A. B. Hickman, T. M. Jenkins, A. Engelman, R. Craigie, and D. R. Davies. Science 266:1981-1986 (1994).
16. T. R. Burke, Jnr., M. R. Fesen, A. Mazumder, J. Wang, A. M. Carothers, D. Grumberger, J. Driscoll, K. Kohn, and Y. Pommier. J. Med. Chem. 38:4174-4178 (1995).
17. R. D. Cramer III, D. E. Paterson, and J. D. Bunce. J. Am. Chem. Soc. 110:5959-5967 (1988).